Market Overview:
The global antigen ELISA kit market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of various diseases, growing demand for early diagnosis and treatment, and technological advancements in ELISA kits. Based on type, the global antigen ELISA kit market can be segmented into direct test and indirect test. The direct test segment is expected to account for a larger share of the global antigen ELISA kit market than the indirect test segment during the forecast period. This can be attributed to factors such as rising demand for rapid diagnosis and easy-to-use kits, growing awareness about direct tests among end users, and technological advancements in this segment. Based on application, the global antigen ELISA kit market can be divided into hospital laboratories, clinic laboratories, research institutes/universities/academic institutions),and other segments (including point-of-care testing (POCT) labs).
Product Definition:
An antigen ELISA kit is a diagnostic tool used to detect the presence of an antigen in a biological sample. The importance of antigen ELISA kits is that they can be used to diagnose infections or diseases caused by the presence of an antigen.
Direct Test:
Direct test is a method of testing for the presence of antibodies in the blood. It is an indirect measure and can only be used to determine if an individual has been exposed to an antigen, which leads to certain disease conditions. The most common use of this technique is in connection with infectious diseases such as HIV, Hepatitis B & C or Tuberculosis (TB).
Indirect Test:
An indirect test is a procedure carried out to detect the presence of an antigen in the human body. The most common indirect tests are radioimmunoassay, enzyme immunoassay (EIA), and chemiluminescence. Indirect tests are used for detecting various infectious agents such as HIV, HCV, HBV, and others.
Application Insights:
The hospital application segment led the global antigen ELISA kit market in 2017. This can be attributed to an increase in the prevalence of chronic diseases, such as cancer and diabetes, which require regular monitoring for detecting any change or fluctuation in the disease state. In addition, a rise in healthcare spending due to an increase number of geriatric population across the globe is further driving this segment growth.
The other application segment includes point-of-care testing and home healthcare testing. Point-of-care tests are used by medical professionals during clinical trials or patient diagnosis for measuring very small amounts of blood samples taken from patients using lancets before sending them directly to a lab for analysis without having any sample handling procedures performed at laboratory facilities other than collection & processing of sample & its transportation to an external facility where analysis is performed (laboratory).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and increasing focus on R&D activities are some factors driving the regional market. Moreover, government initiatives to improve disease management through antigen testing are expected to fuel product demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising incidences of infectious diseases such as Ebola and Zika virus in countries such as India and China.
Growth Factors:
- Increasing demand for early diagnosis of various diseases
- Rising prevalence of target diseases
- Technological advancements in ELISA assay kits
- Growing awareness about benefits of antigen ELISA kits
- Increasing funding for R&D activities in the field of antigen ELISA kit
Scope Of The Report
Report Attributes
Report Details
Report Title
Antigen ELISA Kit Market Research Report
By Type
Direct Test, Indirect Test
By Application
Hospital, Clinic, Other
By Companies
Abcam, XpressBio, Affinity Biologicals, Cell Biolabs, Epitope Diagnostics, Novus Biologicals, Sino Biological, Thermo Fisher Scientific, Affymetrix, Oxford Biomedical, Abcam
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Antigen ELISA Kit Market Report Segments:
The global Antigen ELISA Kit market is segmented on the basis of:
Types
Direct Test, Indirect Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- XpressBio
- Affinity Biologicals
- Cell Biolabs
- Epitope Diagnostics
- Novus Biologicals
- Sino Biological
- Thermo Fisher Scientific
- Affymetrix
- Oxford Biomedical
- Abcam
Highlights of The Antigen ELISA Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Direct Test
- Indirect Test
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antigen ELISA Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Antigen ELISA Kit is a diagnostic tool used to detect the presence of specific antigens in samples.
Some of the key players operating in the antigen elisa kit market are Abcam, XpressBio, Affinity Biologicals, Cell Biolabs, Epitope Diagnostics, Novus Biologicals, Sino Biological, Thermo Fisher Scientific, Affymetrix, Oxford Biomedical, Abcam.
The antigen elisa kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antigen ELISA Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antigen ELISA Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antigen ELISA Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antigen ELISA Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antigen ELISA Kit Market Size & Forecast, 2020-2028
4.5.1 Antigen ELISA Kit Market Size and Y-o-Y Growth
4.5.2 Antigen ELISA Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Direct Test
5.2.2 Indirect Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antigen ELISA Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antigen ELISA Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Direct Test
9.6.2 Indirect Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Direct Test
10.6.2 Indirect Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Direct Test
11.6.2 Indirect Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Direct Test
12.6.2 Indirect Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Direct Test
13.6.2 Indirect Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antigen ELISA Kit Market: Competitive Dashboard
14.2 Global Antigen ELISA Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam
14.3.2 XpressBio
14.3.3 Affinity Biologicals
14.3.4 Cell Biolabs
14.3.5 Epitope Diagnostics
14.3.6 Novus Biologicals
14.3.7 Sino Biological
14.3.8 Thermo Fisher Scientific
14.3.9 Affymetrix
14.3.10 Oxford Biomedical
14.3.11 Abcam
